REDUCED-INTENSITY STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Nishimori, Hisakazu [1 ]
Kubonishi, Shiro [1 ]
Ohnishi, Naoko [1 ]
Kondoh, Shoutaro [1 ]
Ennishi, Daisuke [1 ]
Hara, Yoshitaka [1 ]
Aoyama, Kazutoshi [1 ]
Kondoh, Eisei [1 ]
Maeda, Yoshinobu [1 ]
Niiya, Masami [1 ]
Shinagawa, Katsuji [1 ]
Ikeda, Kazuma [1 ]
Tanimoto, Mitsune [1 ]
机构：
[1] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
    Imataki, Osamu
    Kamioka, Takeshi
    Fukuda, Takashi
    Tanosaki, Ryuji
    Takaue, Yoichi
    SUPPORTIVE CARE IN CANCER, 2010, 18 (12) : 1565 - 1569
  • [22] Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
    Osamu Imataki
    Takeshi Kamioka
    Takashi Fukuda
    Ryuji Tanosaki
    Yoichi Takaue
    Supportive Care in Cancer, 2010, 18 : 1565 - 1569
  • [23] Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia
    Chen, Yi-Bin
    Coughlin, Erin
    Kennedy, Kevin F.
    Alyea, Edwin P.
    Armand, Philippe
    Attar, Eyal C.
    Ballen, Karen K.
    Cutler, Corey
    Dey, Bimalangshu R.
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 981 - 987
  • [24] FAVORABLE OUTCOME OF REDUCED-INTENSITY STEM CELL TRANSPLANTATION FOR ADULT T-CELL LEUKEMIA
    Iwai, F.
    Kaneko, H.
    Tatsumi, G.
    Matsumoto, T.
    Inada, S.
    Sueki, Y.
    Toyooka, N.
    Fujii, S.
    Nakamura, C.
    Watanabe, M.
    Hirata, H.
    Miura, Y.
    Tsudo, M.
    HAEMATOLOGICA, 2012, 97 : 402 - 402
  • [25] Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients
    Narimatsu, H
    Matsumura, T
    Kami, M
    Miyakoshi, S
    Kusumi, E
    Takagi, S
    Miura, Y
    Kato, D
    Inokuchi, C
    Myojo, T
    Kishi, Y
    Murashige, N
    Yugi, K
    Masuoka, Y
    Yoneyama, A
    Wake, A
    Morinaga, S
    Kanda, Y
    Taniguchi, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (06) : 429 - 436
  • [26] Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning
    Kurosawa, Shuhei
    Shimomura, Yoshimitsu
    Itonaga, Hidehiro
    Katayama, Yuta
    Onizuka, Makoto
    Tanaka, Masatsugu
    Kobayashi, Hikaru
    Ozawa, Yukiyasu
    Sawa, Masashi
    Kanda, Junya
    Doki, Noriko
    Fujisawa, Shin
    Uchida, Naoyuki
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Ishiyama, Ken
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (05): : 510e1 - 510e10
  • [27] Excellent outcome of reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with Sezary Syndrome
    Onida, F.
    Saporiti, G.
    Vincenti, D.
    Annaloro, C.
    Tagliaferri, E.
    Motta, B.
    Violetti, S. Alberti
    Berti, E.
    Cortelezzi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S281 - S282
  • [28] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    Nakamura, R.
    Rodriguez, R.
    Palmer, J.
    Stein, A.
    Naing, A.
    Tsai, N.
    Chang, K.
    Slovak, M. L.
    Bhatia, R.
    Spielberger, R.
    Kogut, N.
    Pullarkat, V.
    Kirschbaum, M.
    Forman, S. J.
    O'Donnell, M. R.
    BONE MARROW TRANSPLANTATION, 2007, 40 (09) : 843 - 850
  • [29] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    R Nakamura
    R Rodriguez
    J Palmer
    A Stein
    A Naing
    N Tsai
    K Chang
    M L Slovak
    R Bhatia
    R Spielberger
    N Kogut
    V Pullarkat
    M Kirschbaum
    S J Forman
    M R O'Donnell
    Bone Marrow Transplantation, 2007, 40 : 843 - 850
  • [30] Allogeneic stem cell transplantation with reduced-intensity conditioning in patients with relapsed lymphoma
    Rivas, M.
    Berro, M.
    Belaustegui, S.
    Prates, V.
    Yantorno, S.
    Milone, J.
    Remaggi, G.
    Rolon, J. Martinez
    Milone, G.
    Basquiera, A.
    Garcia, J.
    Sturich, G.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S257 - S258
12345